ConductScience.org, home

Paper35782825

Molecular Insights into Oral Malignancy.

Deshmukh A and 5 others. Indian J Surg Oncol, 2022. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Molecular Insights into Oral Malignancy. Papers, record 35782825. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35782825

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Molecular Insights into Oral Malignancy.
PubMed
Journal
Indian J Surg Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.45
iCite
Revised in PubMed
2023-06-02
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deshmukh AAnuja
2Rao KNKarthik Nagarajahttps://orcid.org/0000-0002-1420-7366
3Arora RDRipu Daman
4Nagarkar NMNitin M
5Singh AAmbesh
6Shetty OSOm Shree

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in35789226Correction to: Molecular Insights into Oral Malignancy.https://conductscience.org/library/papers/35789226

Source PubMed

Download CSV of comments and corrections

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126519755Human telomerase reverse transcriptase (hTERT) promotes cancer invasion by modulating cathepsin D via early growth response (EGR)-1.Cancer Lett2016https://conductscience.org/library/papers/26519755PubMed
222743333Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.Int J Biochem Cell Biol2012https://conductscience.org/library/papers/22743333PubMed
321909502Correlation of serum levels of vascular endothelial growth factor with TNM staging, histopathologic grading, and surgical therapy for oral squamous cell carcinoma.Quintessence Int2011https://conductscience.org/library/papers/21909502PubMed
427802187Long noncoding RNAs in head and neck cancer.Oncotarget2017https://conductscience.org/library/papers/27802187PubMed
527916470Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study.J Oral Maxillofac Surg2017https://conductscience.org/library/papers/27916470PubMed
625979390Molecular biology and immunology of head and neck cancer.Surg Oncol Clin N Am2015https://conductscience.org/library/papers/25979390PubMed
722903315Free flap reconstruction in patients with advanced oral squamous cell carcinoma: analysis of patient survival and cancer recurrence.Microsurgery2012https://conductscience.org/library/papers/22903315PubMed
820415598Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma.Expert Opin Investig Drugs2010https://conductscience.org/library/papers/20415598PubMed
921244495miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma.J Oral Pathol Med2011https://conductscience.org/library/papers/21244495PubMed
1011147671Oncogenes and angiogenesis: signaling three-dimensional tumor growth.J Investig Dermatol Symp Proc2000https://conductscience.org/library/papers/11147671PubMed
1126711175Fibroblast growth factor receptor 3 protein is overexpressed in oral and oropharyngeal squamous cell carcinoma.Cancer Med2016https://conductscience.org/library/papers/26711175PubMed
1220198305Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.Int J Mol Med2010https://conductscience.org/library/papers/20198305PubMed
1319706812Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection.Clin Cancer Res2009https://conductscience.org/library/papers/19706812PubMed
1417942672Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17942672PubMed
1519249681Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis.Cancer Cell2009https://conductscience.org/library/papers/19249681PubMed
1625631445Comprehensive genomic characterization of head and neck squamous cell carcinomas.Nature2015https://conductscience.org/library/papers/25631445PubMed
1725406187Notch1 mutations are drivers of oral tumorigenesis.Cancer Prev Res (Phila)2015https://conductscience.org/library/papers/25406187PubMed
1825818339Immune evasion in cancer: Mechanistic basis and therapeutic strategies.Semin Cancer Biol2015https://conductscience.org/library/papers/25818339PubMed
1920967874Lymph node ratio as an independent prognostic factor in oral squamous cell carcinoma.Head Neck2011https://conductscience.org/library/papers/20967874PubMed
2022318752Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling.Cancer Prev Res (Phila)2012https://conductscience.org/library/papers/22318752PubMed

See all 93 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
40299277The Limitations of Artificial Intelligence in Head and Neck Oncology.Adv Ther2025https://conductscience.org/library/papers/40299277PubMed
40070988Evaluation of Methylation and Changes in the Transcriptomics and Proteomics of the GRHL3, PHLDA3, and in Patients with Head and Neck Squamous Cell Carcinoma.Indian J Otolaryngol Head Neck Surg2025https://conductscience.org/library/papers/40070988PubMed
40070747The Chimeric Antero-Lateral Thigh Flap and Vastus Lateralis Muscle Flap for the Infratemporal Fossa Reconstruction in Oral Cancer Defects.Indian J Otolaryngol Head Neck Surg2025https://conductscience.org/library/papers/40070747PubMed
39766175Saliva in Balancing Oral and Systemic Health, Oral Cancer, and Beyond: A Narrative Review.Cancers (Basel)2024https://conductscience.org/library/papers/39766175PubMed
39559102An Increase in the Chemokine Mediators (CCL28 and CCR10) Associated with the Progression of Oral Squamous Cell Carcinoma: A Cross-Sectional Investigation.Indian J Otolaryngol Head Neck Surg2024https://conductscience.org/library/papers/39559102PubMed
39404966SNRPE, an Oncofetal Protein: can be a Diagnostic Marker and Therapeutic Target for Oral Cancers?Head Neck Pathol2024https://conductscience.org/library/papers/39404966PubMed
39188842C-Jun Transcription Factor Oncogenic Activation in Oral Carcinoma.Maedica (Bucur)2024https://conductscience.org/library/papers/39188842PubMed
39062890Identification of Stage-Specific microRNAs that Govern the Early Stages of Sequential Oral Oncogenesis by Strategically Bridging Human Genetics with Epigenetics and Utilizing an Animal Model.Int J Mol Sci2024https://conductscience.org/library/papers/39062890PubMed
38528913Salivary miRNAs as auxiliary liquid biopsy biomarkers for diagnosis in patients with oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis.Front Genet2024https://conductscience.org/library/papers/38528913PubMed
38473236HOXA1 3'UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma.Cancers (Basel)2024https://conductscience.org/library/papers/38473236PubMed
37628629Review of Disease-Specific microRNAs by Strategically Bridging Genetics and Epigenetics in Oral Squamous Cell Carcinoma.Genes (Basel)2023https://conductscience.org/library/papers/37628629PubMed
36376957Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).Cancer Cell Int2022https://conductscience.org/library/papers/36376957PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35782825

GET https://conductscience.org/api/papers/v1/35782825/references?page=2